Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018390
Fusion event
HBV-TNPO3 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1782
Integrated sequence
TGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGG| |CTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGT
Host Sequence
Chromosome
chr7
Cytoband
q32.1
Reference genome
End
128594328/128954274 (Hg38)
Location type
Exon1
Target gene
miRNAs that regulate target gene
hsa-mir-375 ; hsa-mir-34a-5p ; hsa-mir-30a-5p ; hsa-mir-24-3p ; hsa-mir-16-5p ; hsa-mir-423-3p ; hsa-mir-149-5p ; hsa-mir-15b-5p ; hsa-mir-17-5p ; hsa-mir-210-3p ; hsa-mir-6776-5p ; hsa-mir-7977 ; hsa-mir-143-5p ; hsa-mir-4284 ; hsa-mir-6499-3p ; hsa-mir-20b-3p ; hsa-mir-5693 ; hsa-mir-383-3p ; hsa-mir-2114-5p ; hsa-mir-5588-3p ; hsa-mir-519e-5p ; hsa-mir-515-5p ; hsa-mir-362-3p ; hsa-mir-329-3p ; hsa-mir-629-3p ; hsa-mir-665 ; hsa-mir-711 ; hsa-mir-7160-5p ; hsa-mir-3934-3p ; hsa-mir-4722-5p ; hsa-mir-6884-5p ; hsa-mir-485-5p ; hsa-mir-1827 ; hsa-mir-767-3p ; hsa-mir-4649-3p ; hsa-mir-3664-3p ; hsa-mir-4433a-3p ; hsa-mir-4459 ; hsa-mir-4768-3p ; hsa-mir-4478 ; hsa-mir-4419b ; hsa-mir-3929 ; hsa-mir-940 ; hsa-mir-6893-5p ; hsa-mir-4695-5p ; hsa-mir-6808-5p ; hsa-mir-4684-5p ; hsa-mir-6771-3p ; hsa-mir-3675-3p ; hsa-mir-548c-3p ; hsa-mir-6516-3p ; hsa-mir-1257 ; hsa-mir-4286 ; hsa-mir-3607-5p ; hsa-mir-4760-3p ; hsa-mir-125a-5p ; hsa-mir-125b-5p ; hsa-mir-345-3p ; hsa-mir-4319 ; hsa-mir-4732-3p ; hsa-mir-4793-5p ; hsa-mir-5196-3p ; hsa-mir-6515-3p ; hsa-mir-670-5p ; hsa-mir-6749-3p ; hsa-mir-7113-3p
Nearest miRNA
hsa-mir-10525/Upstream/746330; hsa-mir-10399/Downstream/816109;
Nearest CpG islands
None/Target, chr7-CpG: 39/Upstream/15571, chr7-CpG: 60/Downstream/100185
Upstream sequence
CAGGAATAGTTTGCTCTATGGTGTATCCACCATGCCAAGCAGCCCACTTTATCCTTTCCAAAGGGACCATATGTCCAGGCCCAGGTGAACAGACAGTGAA
Downstream sequence
CTGATGGCTGTGAAGGGCTGCACTCCTTTGAAACATTAAGATCTGCTTTGGGCTTCCCTCTTCGGCCTCACCCTCCCCTTAAAATCAAGTCATTTCCACA
Target sequence
T
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.